United States · FDA National Drug Code directory
FULVESTRANT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16714-070_244e8f58-8aba-5ede-0b9d-a566f1021cfb
- Product NDC
- 16714-070
- Form
- INJECTION, SOLUTION
- Composition / generic term
- fulvestrant
- Labeler
- Northstar Rx, LLC,
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210823
- Source listing expiry
- 20261231
Source-listed ingredients
- FULVESTRANT — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, GLASS in 1 CARTON (16714-070-02) / 5 mL in 1 SYRINGE, GLASS (16714-070-01) · 16714-070-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →